Androgen deprivation therapy (ADT) is an effective and widely prescribed treatment for prostate cancer (PCa), but it is associated with multiple treatment-induced adverse effects that impact on various musculoskeletal and cardiometabolic health outcomes. Emerging research has shown that ADT is also associated with cognitive impairment, which has been linked to a loss of independence, increased falls and fracture risk and greater use of medical services. The aim of this review is to outline the evidence related to the effect of ADT use on cognitive function, and propose a role for exercise training as part of usual care to prevent and/or manage cognitive impairments for PCa survivors on ADT. The following results have been obtained from this study. ADT has been shown to adversely affect specific cognitive domains, particularly verbal memory, visuomotor function, attention and executive function. However, current clinical guidelines do not recommend routine assessment of cognitive function in these men. No studies have examined whether exercise training can preserve or improve cognitive function in these men, but in healthy adults', multimodal exercise training incorporating aerobic training, progressive resistance training (PRT) and challenging motor control exercises have the potential to attenuate cognitive decline. In conclusion, as treatment with ADT for men with PCa has been associated with a decline in cognition, it is recommended that cognitive function be routinely monitored in these men and that regular exercise training be prescribed to preserve (or improve) cognitive function. Assessment of cognition and individualised exercise training should be considered in the usual treatment plan of PCa patients receiving ADT.
Introduction
Prostate cancer (PCa) is the most prevalent nondermatological male cancer globally (Australian Institute of Health and Welfare 2014). Despite improved PCa survivorship, men suffer a range of adverse effects from treatment. Androgen deprivation therapy (ADT) is a commonly prescribed treatment that reduces androgens, such as testosterone, to castration levels in an attempt to slow tumour progression and improve overall survival in men with appropriately selected locally advanced and metastatic disease (Grossmann et al. 2013) . ADT prescription has increased for all stages and grades of PCa (Shahinian et al. 2005) . Despite improving survival, research has consistently reported a range of adverse effects associated with the use of ADT including deterioration in 24:4 musculoskeletal health, an increase in cardiometabolic risk and a reduction in health-related quality of life (HR-QoL) (Gardner et al. 2014) . A growing body of evidence indicates that ADT may also adversely affect cognitive function, including information processing (Green et al. 2002) , spatial abilities (Cherrier et al. 2009 ) and memory (Bussiere et al. 2005) , visuo-motor speed (McGinty et al. 2014 ) and executive function (Cherrier et al. 2009 ). However, current guidelines for the assessment and management of PCa for men treated with ADT do not recommend an assessment of cognitive function or methods for attenuating cognitive decline associated with treatment (Bussiere et al. 2005 , Grossmann & Zajac 2011 . There is emerging evidence that exercise training can play an important role in minimising the risk of cognitive deterioration with advancing age in healthy older adults (Colcombe & Kramer 2003) . Importantly, regular exercise may also assist in managing various other adverse effects of ADT, such as cardiometabolic risk, which have been linked to cognitive impairment and related disorders (Papachristou et al. 2015) . The aim of this review is to outline the evidence related to the effect of ADT use on cognitive function and propose a role for exercise training as part of usual care to prevent and/or manage cognitive impairments for PCa survivors on ADT.
The effects of androgen deprivation on cognitive function
Cognitive decline is part of the normal ageing process, particularly in the domains of information processing speed, memory, reasoning, reaction time and spatial abilities (Salthouse 2009 ). However, in men with PCa treated with ADT, the rate of decline in these processes appears to be accelerated (McGinty et al. 2014) . Furthermore, the use of ADT has been associated with an almost two-fold increased risk for developing Alzheimer's disease (AD), with the risk increasing with treatment duration (Nead et al. 2016) . Thirteen prospective studies have objectively assessed cognitive function in patients receiving ADT (Table 1) (Green et al. 2002 , Cherrier et al. 2003 , 2009 , Salminen et al. 2003 , Almeida et al. 2004 , Alibhai et al. 2010 , Matousek & Sherwin 2010 , Mohile et al. 2010 , Chao et al. 2012 , Tan et al. 2013 , Gonzalez et al. 2015 . Five of these studies reported no effect (Almeida et al. 2004 , Matousek & Sherwin 2010 , Mohile et al. 2010 , Chao et al. 2012 , Tan et al. 2013 , which is likely related in part to methodological differences in participant characteristics, study design and analyses. For instance, four of the 11 studies did not include non-ADT control participants (Almeida et al. 2004 , Matousek & Sherwin 2010 , Mohile et al. 2010 , Tan et al. 2013 .
Longitudinal studies of men with various cancers have identified that 16-48% had lower-than-normal cognitive performance prior to cancer treatment (Janelsins et al. 2014 , Wefel et al. 2015 . As cognitive function is rarely measured prior to ADT administration, many studies are observational, and few studies have provided a measure of estimated cognitive reserve. This is important because cognitive reserve provides a retrospective estimated baseline for cognitive function (Roldán-Tapia et al. 2012) , and the degree of cognitive decline can be a function of ADT treatment duration (Nead et al. 2016) . The National Adult Reading Test (NART), which provides a measure of reading intelligence that is more stable over time than other facets of intelligence, is one example of a relatively simple and easy-to-administer neurocognitive instrument that estimates cognitive reserve (Bright et al. 2016) . To determine the cognitive performance in PCa survivors on ADT, standardised, objective measures of cognitive domains shown to be affected by ADT should be included (Wefel et al. 2011) .
As indicated earlier, there is a growing body of evidence that ADT can accelerate cognitive decline; however, there has been only one longitudinal randomised controlled trial (RCT) examining cognitive function in men with PCa prior to and during ADT administration that also included a non-ADT control group (Green et al. 2002) . Green and coworkers (Green et al. 2002) objectively assessed cognitive function in 77 men (mean age; 73 years) with PCa prior to commencing ADT, and six months after random allocation to ADT, or a watchful waiting control (Green et al. 2002) . In 24 of the 50 men randomised to ADT, significant declines were evident in one or more cognitive tests at 6 months when compared to non-ADT controls, who showed no cognitive decline (Green et al. 2002) . Importantly, the ADT group did not show a practice effect in comparison to the non-ADT controls, which may indicate a lack of learning ability (Green et al. 2002) . A limitation of this study was the absence of a healthy control group, thus, potential cognitive effects linked to the cancer itself were not differentiated from the potential adverse effects of ADT (Wefel et al. 2011) . Nevertheless, these findings highlight the negative influence of ADT on certain cognitive domains, including visuomotor control, verbal fluency, verbal memory, visual memory and attention (Green et al. 2002) .
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An important question that requires further investigation is whether ADT leads to a greater rate of deterioration in specific cognitive domains. Several studies have reported that spatial memory and spatial ability are often adversely affected by ADT (Cherrier et al. 2003 , 2009 , Jenkins et al. 2005 . Other studies have reported adverse No effect in any domain tested BOLD, blood oxygenation level dependent; fMRI, functional magnetic resonance imaging; NA, not assessed.
effects of ADT on spatial memory, spatial ability, verbal memory and working memory (Table 1) (Green et al. 2002 , Salminen et al. 2003 , Cherrier et al. 2010 , with reports that at least one of these measures of cognitive function decline by 47-69% in men on ADT over 9-12 months (Cherrier et al. 2003 , Jenkins et al. 2005 . Brain imaging studies have also shown that the adverse effects to spatial ability and memory are related to changes in cerebral function and brain volume (Cherrier et al. 2009 , Chao et al. 2012 . However, a meta-analysis of 14 studies that objectively measured cognitive function in PCa survivors on ADT confirmed that the largest effect size in relation to ADT and cognitive function was for the visuomotor control domain (effect size, g = −0.67) (McGinty et al. 2014) , which may indicate an effect of reduced testosterone on tasks involving both vision and manual manipulation.
One of the challenges in comparing the results across different studies is the inconsistent definitions used for cognitive impairment or decline. For example, Mohile and coworkers (Mohile et al. 2010) defined cognitive impairment as scoring >1.5 standard deviation (s.d.) below the age-and education-adjusted population reference means (Mohile et al. 2010) . Alibhai and coworkers (Alibhai et al. 2010) defined cognitive decline as a reduction of at least one s.d. in at least one cognitive test (Alibhai et al. 2010) , whereas Gonzalez and coworkers (Gonzalez et al. 2015 ) defined impaired cognitive performance as a score >1.5 s.d. below population norms on two or more tests or >2 s.d. below published norms on one test (Wefel et al. 2011 , Gonzalez et al. 2015 . A more consistent interpretation of cognitive impairment would assist in evaluating the effects of ADT on cognitive performance (Gonzalez et al. 2015) . However, recent longitudinal trials have shown greater rigour in test selection (for example including the NART, Hopkins verbal learning test, digit span and controlled oral word association test) and study design for assessing cognitive function in PCa patients, which assists with the validity of inter-study comparisons (Gonzalez et al. 2015) .
In summary, the available evidence indicates that ADT adversely affects the cognitive domains of verbal, visual, spatial and working memory (Green et al. 2002 , Beer et al. 2006 , Cherrier et al. 2009 ), spatial reasoning and spatial ability (Cherrier et al. 2003 (Cherrier et al. , 2009 , psychomotor and visuomotor function (Green et al. 2004 , Salminen et al. 2004 , auditory learning (Bussiere et al. 2005) , executive function and processing speed (Green et al. 2002 , Cherrier et al. 2009 , with the most significant effects on visuomotor ability (McGinty et al. 2014) . Given that a randomised study design of ADT use is not ethical for men with advanced PCa, future observational studies that aim to measure cognitive function in PCa patients should closely adhere to current guidelines for assessing the cognitive function in cancer patients, such as those recommended by the International Cognition and Cancer Task Force (ICCTF) (Wefel et al. 2011) . A brief overview of these guidelines will be discussed below.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Guidelines for assessing cognitive function in prostate cancer patients
Neuropsychological assessment is indicated where treatment for a disease influences cognitive function and should be performed by (or under the guidance of) a psychologist (Harvey 2012) . It is important to supplement cognitive function testing with the assessment of other factors that may contribute to cognitive dysfunction, such as mood and motivational state (Harvey 2012) . In men treated with ADT, consideration should also be given to the effects of confounding variables such as age, education levels, depressive symptoms, fatigue and hot flash interference (Nelson et al. 2008 , Gonzalez et al. 2015 . The ICCTF guidelines for the assessment of cognitive function in chemotherapy patients (Wefel et al. 2011) have also been applied in patients with PCa (Gonzalez et al. 2015) and recommend that validated, objective measures of cognitive function be used in cancer patients, which assess those domains shown to be affected (Wefel et al. 2011) . Where possible, clinical significance should be determined according to the respective norms or cut points for each specific neurological test (Wefel et al. 2011 ). Impaired cognitive performance should be uniformly determined by a performance of 1.5 s.d. below population norms on two or more tests or 2 s.d. below published norms on one test (Wefel et al. 2011) . Cognitive test selection should include objective tests that have been previously shown to differentiate the effects of ADT in PCa survivors (Wefel et al. 2011) and which include specific cognitive domains such as visuomotor and visuospatial ability, attention, working memory, spatial memory, spatial ability, verbal memory and executive functions (Green et al. 2002 , Cherrier et al. 2003 , 2009 , Salminen et al. 2004 , Bussiere et al. 2005 , Beer et al. 2006 . Commonly used neuropsychological tests of Published by Bioscientifica Ltd. cognitive function which meet these criteria are shown in Table 2 .
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Effects of exercise training on cognitive function in men on ADT
Although exercise has been shown to be important for the prevention and management of cognitive impairment in cancer patients generally (Zimmer et al. 2016) , various reviews have also associated exercise interventions with improved cognitive function in men treated with ADT (Trost et al. 2013 , Ahmadi & Daneshmand 2014 , Gardner et al. 2014 , Nguyen et al. 2015 . However, as shown in Table 3 , many of these exercise trials are limited by the use of a generalised quality of life (QoL) questionnaire containing subjective measures of cognitive function, such as the European Organization for Research and Treatment of Cancer quality of life questionnaire (EORTC-QLQ C30) (Culos-Reed et al. 2007 , Livingston et al. 2011 , Oh et al 2012 , Cormie et al. 2014a , Buffart et al. 2015 . Subjective reports of cognitive function have not been validated as a means to assess cognitive function in cancer patients and are more closely associated with mood than objective measures of cognitive function (Wefel et al. 2011) .
There is currently little evidence available to support the benefits of exercise training for improving cognitive function in PCa survivors receiving ADT, but the results from studies of older adults and non-PCa cancer survivors are promising. Meta-analyses indicate that exercise can reduce the risk for developing dementia and AD by 28% and 45%, respectively, with the volume of exercise training inversely related to dementia risk (Hamer & Chida 2009 ). Indeed, greater cardiovascular fitness has shown to be positively associated with cognitive performance in older adults (mean 0.5 s.d. benefit), independent of cognitive task type, exercise training method or participants' characteristics (Colcombe & Kramer 2003) .
The mechanisms underlying these improvements in cognitive function may relate to changes in brain structure. For example, an RCT of 120 healthy older adults (mean age 67 years) found that aerobic exercise training was associated with improved spatial memory and hippocampal volume in comparison to a nonexercising control (Erickson et al. 2011) . In another RCT including 120 older adults (mean age 67 years) who completed 12 months of aerobic exercise training (10-40 min of walking at 50-75% maximum heart rate reserve) that increased cardiovascular fitness, there was a corresponding increase in hippocampal volume; an area of the brain which is vulnerable to age-related degradation (Erickson et al. 2011) . Collectively, these findings provide some evidence that aerobic training that is associated with an improvement in fitness may lead to an improvement in cognitive function in older people.
More recent research has found that progressive resistance training (PRT) and multimodal exercise programmes incorporating aerobic and resistance training can also aid cognitive function in older adults (Liu-Ambrose et al. 2010 , Nagamatsu et al. 2012 , Fragala et al. 2014 . For instance, moderate-to-highintensity PRT (70-85% of one-repetition maximum (1-RM)) has been shown to improve memory and attention in older men (Cassilhas et al. 2007 ) and spatial awareness in older adults (Fragala et al. 2014) . Combined or multimodal exercise interventions that include a motor component (movement speed, balance, motor coordination and flexibility) have also been shown to improve cognitive function in older adults (VoelckerRehage et al. 2010) . Although questions still remain as to the optimal type and dose of exercise that is most effective to improve cognitive function in older adults, a meta-analysis of single or bimodal exercise trials indicated a small-to-moderate effect on cognitive performance with combined aerobic and PRT compared to aerobic training alone in older adults (Colcombe & Kramer 2003) .
Domains of cognitive function Description Neurocognitive tests
Visuo-motor ability Synchronization of visual perception and motor skills -Card rotations -Environmental memory task encoding and recognition judgment of line orientation -Puget sound route learning test -Vandenberg and Kuse mental rotation test -Visuo-motor integration test -block design Data from Kulkarni & Moningi (2015) and McGinty et al. (2014) . D-KEFS, Delis-Kaplan executive function system; WAIS-R, Wechsler adult intelligence scale-revised; WAIS-III, Wechsler adult intelligence scale-third edition; WMS-R, Wechsler memory scales-re-vised edition; WMS-III, Wechsler memory scales-third edition. Others have reported that more intense exercise leads to a greater effect on subsequent cognitive performance than light or moderate exercise .
Longer duration interventions (6-12 months) have also been associated with improved neural connectivity and activation in the brain in older adults (Voss et al. 2010) . For example, one-year long study compared aerobic exercise training for 10-40 min three times per week at 50-75% maximum heart rate reserve (n = 30) to moderate intensity stretching and balance 
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exercises (n = 35) on neural connectivity and cognitive functions in older adults (median age 67.5 years, median VO2 peak 21 mL/kg/min) and reported significant withingroup improvements in measures of neural connectivity in brain networks vulnerable to dysfunction with ageing in the aerobic training group (Voss et al. 2010) . Furthermore, these changes were positively correlated with changes in executive function in the aerobic training group, but the stretching/balance group also showed alterations in functional connectivity, possibly representing experience-dependent plasticity (Voss et al. 2010) . These findings may be relevant to men with PCa treated with ADT as there is some evidence from a study of 30 PCa survivors (median age 68 years), which found that 6 months of ADT was associated with decreased grey matter volume, reduced brain functional connectivity and reduced neural activations during cognitive control tasks (Chao et al. 2012 (Chao et al. , 2013 . Collectively, the current evidence indicate that regular exercise training can offer protective benefits to cognitive function in healthy older adults, but in men with PCa receiving ADT, the direct link between exercise and cognitive function has not been established. Given the strength of evidence for cognitive decline associated with ADT use for men with PCa and the confirmed benefits of exercise training for cognitive function in older adults, it is reasonable to infer that these benefits will translate to PCa survivors on ADT. It has previously been shown that PRT can provide substantial benefits to musculoskeletal health in men treated with ADT for PCa (Cormie et al. 2013) and that aerobic training can improve cardiometabolic risk factors that have been implicated in cognitive decline, but the effects of these modes of exercise training on cognitive function have not been assessed in these men. Exercise training can also reduce the risk of developing diabetes, obesity and cardiovascular disease (Roque et al. 2013) , which are prevalent in men treated with ADT (Galvão et al. 2009 , Keogh & MacLeod 2012 and are also risk factors for cognitive decline and neurodegeneration (Cotman et al. 2007) . Given the need to also redress functional deficits, losses in bone mineral density and muscle mass and increases in cardiometabolic risk factors in PCa survivors on ADT, multimodal exercise programmes which include a combination of aerobic, PRT and motor control components are likely to provide the greatest overall benefits (Voelcker-Rehage et al. , Keogh & MacLeod 2012 .
Although there are currently no data on the effects of exercise training on cognitive function specific to ADT and non-ADT men with PCa, a review of trials in women with breast cancer and mixed cancer types show a positive effect of exercise training on cognitive function (Zimmer et al. 2016) . Thus, despite the lack of direct evidence, there is indirect evidence to support a role for exercise training in attenuating the negative effects of ADT on cognitive function. However, given the unique physiological profile of this patient group, there remains a need for more adequately powered RCTs to investigate the effects of exercise on cognitive function in these men. These studies should include the use of objective, standardised measures of cognitive function.
Exercise guidelines for management of ADT adverse effects
In the management of ADT-related complications, an allied health professional (such as an Accredited Exercise Physiologist in the Australian health care system) should be engaged to assess the patient and individualise exercise prescription (Cheema et al. 2014) . The current exercise guidelines for cancer survivors advocate normal daily activities and exercise according to age-appropriate physical activity guidelines during and after nonsurgical treatments, with modifications required in the instance of metastatic bone or cardiac disease (Schmitz et al. 2010) . These guidelines do not include specific prescription parameters for addressing the cognitive decline associated with ADT (Schmitz et al. 2010) . There is currently insufficient evidence in the literature to guide precise exercise prescription guidelines in terms of the frequency, intensity and duration required for men with PCa treated with ADT to attenuate cognitive decline. With respect to the optimal dose for improving or protecting cognitive function in older adults without PCa, emerging evidence indicates that moderate-and high-intensity (60-80% of maximal strength) PRT performed at least twice per week, including at least two sets of 7-10 exercises performed for 2-12 months may positively affect cognitive function (Yu-Kai et al. 2012) . However, most of the available data from older adults indicate that the largest effect sizes in terms of exercise training occur with programmes of longer duration (>6 months), sessions of 31-45 min at moderate intensities and consisting of combined aerobic and resistance training performed a minimum of three days per week (Colcombe & Kramer 2003 , Bherer et al. 2013 .
Many cancer survivors are motivated to seek advice on optimal lifestyle advice to aid recovery, optimise management of treatment side effects and improve QoL (Rock et al. 2012) . Advice given by a health care provider or physician has consistently been shown to 24:4 facilitate health behaviour changes in cancer patients (Rock et al. 2012) . A 12-week RCT including 100 PCa survivors on ADT (mean age; 71 years) indicated that an intervention involving exercise and dietary advice was feasible and induced sustainable behaviour changes after intervention (Bourke et al. 2012) . However, advice may be conflicting and unsupported by data (Rock et al. 2012) , indicating a need for consistent, evidence-based recommendations.
Conclusion
There is convincing evidence for the adverse effects of ADT on cognitive function in men treated with ADT for PCa, and appropriately timed cognitive assessment is warranted. When a measure of pre-treatment or prediagnosis cognitive function is not feasible, a reliable measure of estimated cognitive reserve should be implemented at baseline with a battery of neurocognitive tests which comply with ICCTF guidelines (Wefel et al. 2011) . Emerging evidence indicates that a structured and targeted exercise intervention focussing on improvements in aerobic fitness, musculoskeletal health and function may have multiple benefits for men treated with ADT in terms of addressing such adverse effects as reduced bone mineral density, an adverse metabolic and cardiac health profile, sexual dysfunction, reduced QoL and changes in body composition (Cormie et al. 2015) . Evidence from older, healthy populations supports the role of exercise as being protective against cognitive decline, and exercise guidelines for those with cardiovascular and metabolic disease should be used to inform exercise prescription in PCa survivors treated with ADT who present with such comorbidities. Although these exercise training recommendations are not intended to replace standard care, due consideration to risk for cognitive impairment is recommended for PCa survivors on ADT. Individualised multimodal exercise training is recommended to compliment usual care and may maximise cognitive function for this vulnerable population.
